Corcept Therapeutics, Inc. (CORT)
123.20
+0.95
(+0.78%)
USD |
NASDAQ |
Aug 24, 16:00
123.20
0.00 (0.00%)
After-Hours: 19:20
Corcept Therapeutics Debt to Equity Ratio : 0.0133 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0133 |
| March 31, 2026 | 0.0151 |
| December 31, 2025 | 0.0094 |
| September 30, 2025 | 0.0101 |
| June 30, 2025 | 0.0104 |
| March 31, 2025 | 0.01 |
| December 31, 2024 | 0.0102 |
| September 30, 2024 | 0.0106 |
| June 30, 2024 | 0.0095 |
| March 31, 2024 | 0.0001 |
| December 31, 2023 | 0.0003 |
| September 30, 2023 | 0.0005 |
| June 30, 2023 | 0.0007 |
| March 31, 2023 | 0.0011 |
| December 31, 2022 | 0.0023 |
| September 30, 2022 | 0.0036 |
| June 30, 2022 | 0.0051 |
| March 31, 2022 | 0.0069 |
| December 31, 2021 | 0.0014 |
| September 30, 2021 | 0.0019 |
| June 30, 2021 | 0.003 |
| March 31, 2021 | 0.004 |
| December 31, 2020 | 0.0049 |
| September 30, 2020 | 0.0062 |
| June 30, 2020 | 0.0077 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0076 |
| December 31, 2019 | 0.0093 |
| September 30, 2019 | 0.0023 |
| June 30, 2019 | 0.0039 |
| March 31, 2019 | 0.0053 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.0691 |
| March 31, 2017 | 0.2039 |
| December 31, 2016 | 0.3544 |
| September 30, 2016 | 0.5993 |
| June 30, 2016 | 0.8691 |
| March 31, 2016 | 1.242 |
| December 31, 2015 | 1.488 |
| September 30, 2015 | 2.199 |
| June 30, 2015 | 2.727 |
| March 31, 2015 | 3.101 |
| December 31, 2014 | -10.00 |
| September 30, 2014 | -26.31 |
| June 30, 2014 | 10.15 |
| March 31, 2014 | 3.747 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Abeona Therapeutics, Inc. | 0.1552 |
| Liquidia Corp. | 0.9374 |
| Indivior Pharmaceuticals, Inc. | -2.447 |
| Crinetics Pharmaceuticals, Inc. | 0.0396 |
| Forum Markets, Inc. | 0.203 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 888.70M |
| Total Liabilities (Quarterly) | 182.93M |
| Shareholders Equity (Quarterly) | 705.78M |
| Current Ratio | 2.830 |
| Net Debt Paydown Yield | -0.01% |